Serono
From Freepedia
| Serono | |
|---|---|
| Image:Serono logo.gif | |
| Type | Stock corporation |
| Founded | 1987 |
| Location | Geneva, Switzerland (Headquarters) |
| Key people | Ernesto Bertarelli CEO and Vice Chairman of the Board |
| Industry | Pharmaceutical |
| Products | Specialty goods |
| Revenue | $US ~2.5 billion (2004) |
| Website | http://www.serono.com |
Serono is a biotechnology company headquartered in Geneva, Switzerland. The company was incorporated in 1987 and the holding company, Ares-Serono S.A., changed its name to Serono S.A. in May 2000.[1] The company develops and markets pharmaceuticals in the fields of Reproductive Health, Multiple Sclerosis and Growth & Metabolism. It is world-leader in the infertility market with an estimated market share of 60%, making it the third largest biotechnology company in the world. Serono's most important product accounted for 31.6% of the company's sales in 2004. Currently the company has a partnership in product development with Genentech Inc., a US biotechnology company.
Facilities
The headquarters is located in Geneva, Switzerland. Research and development facilities are maintained in Geneva, Switzerland, Boston, USA, Évry, France and Ardea, Italy. Main manufacturing sites are in Switzerland, Italy, Spain and France; a fifth facility in Israel was closed in 2004 owing to its obsolescence.[2]
External links
Notes
- ^ 2002 Form 20-F. Retrieved July 3, 2005.
- ^ 2004 Form 20-F. Retrieved July 3, 2005.
Categories: Companies traded on NASDAQ | Companies based in California | Biotechnology companies | Multinational corporations | Pharmaceutical companies | Medical corporation stubs
